Inflammatory Bowel Diseases (IBD) are now widely receiving attention. There are many reasons why
people get IBD; for example, environment, smoking, family heredity, intestinal microbiota and so on. Antibiotics
have not been proven effective and those suffering from IBD have begun to look for other effective drugs to treat
the chronic disease. Bioactive peptides are a good candidate among alternative drugs tested so far, and have been
seen to control bodily growth, development, immune regulation and metabolism. This paper will review the literature
describing the effects of bioactive peptides on intestinal inflammation. Studies conducted using in vivo
models and clinical trials provide evidence that bioactive peptides can be effective in mitigating intestinal inflammation.